Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5646]

Protein implicated in tumour growth found to be heavily associated with pancreatic cancer

Protein implicated in tumour growth found to be heavily associated with pancreatic cancer

ASH 2023: Third-generation anti-CD19 CAR T-cells demonstrate efficacy without neurotoxicity in B-cell lymphoma phase 1 clinical trial

ASH 2023: Third-generation anti-CD19 CAR T-cells demonstrate efficacy without neurotoxicity in B-cell lymphoma...

Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate cancer

Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate...

FDA grants accelerated approval to pirtobrutinib for chronic lymphocytic leukaemia and small lymphocytic lymphoma

FDA grants accelerated approval to pirtobrutinib for chronic lymphocytic leukaemia and small lymphocytic lymphoma

SABCS 2023: Potentially targetable fusion RNAs may be more common in metastatic breast cancer than previously realised

SABCS 2023: Potentially targetable fusion RNAs may be more common in metastatic breast cancer than previously...

SABCS 2023: Some breast cancer survivors may safely de-escalate mammography three years after surgery

SABCS 2023: Some breast cancer survivors may safely de-escalate mammography three years after surgery

ESMO 2023: Immunotherapy added to first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

ESMO 2023: Immunotherapy added to first-line standard therapy significantly improves survival in metastatic or...

A novel targeted molecular therapy for drug-resistant biliary tract cancer

A novel targeted molecular therapy for drug-resistant biliary tract cancer

Applications of macrocyclic molecules in cancer therapy: Target cancer development or overcome drug resistance

Applications of macrocyclic molecules in cancer therapy: Target cancer development or overcome drug resistance

Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood–brain barrier and exhibits potent activity against glioblastoma

Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood–brain...

More from ecancer